Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Multi Cap Fund median (28 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | Baroda BNP Paribas Multi Cap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹107.98 |
| 26 Aug 2009 | ₹89.12 |
| 08 May 2011 | ₹102.29 |
| 17 Jan 2013 | ₹103.58 |
| 30 Sep 2014 | ₹122.87 |
| 11 Jun 2016 | ₹121.19 |
| 21 Feb 2018 | ₹133.54 |
| 04 Nov 2019 | ₹113.39 |
| 16 Jul 2021 | ₹140.01 |
| 28 Mar 2023 | ₹135.73 |
| 08 Dec 2024 | ₹219.99 |
| 20 Aug 2026 | ₹188.52 |
| Metric | Baroda BNP Paribas · Regular · IDCW NAV ₹52.67 Very High risk ★☆☆☆☆ | Category median Multi Cap Fund · 28 funds |
|---|---|---|
| -3.82% | +4.94% | |
| +6.01% | +10.91% | |
| +5.88% | +10.25% | |
| +4.45% | +6.97% | |
| +3.16% | +12.72% | |
| +3.90% | — | |
| +5.98% | +14.29% | |
| +5.10% | +11.03% | |
| +4.22% | +5.66% | |
| Risk | ||
| 15.55% | 15.45% | |
| -0.03 | 0.28 | |
| -0.04 | 0.37 | |
| -57.66% | -22.16% | |
| Nifty 500 | — | |
| -5.28% | -0.86% | |
| 0.97 | 1.02 | |
| 83.8% | 101.7% | |
| 109.7% | 103.8% | |
| 2.28% | 2.17% | |
| ₹3,226Cr | ₹3,638Cr | |
| 1.00% | — | |
| None | — | |
| ₹250 | — | |
| ₹5.00K | — | |
| 80% | 53% | |
| Sanjay Chawla · 10.8y | — | |
| 03 Apr 2006 | — | |
| 64 | — | |
| 24.2% | — | |
| -0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.